Respirology 2021
Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort
Respirology. 2021 Oct;26:982–988
Addition of zolpidem to combination therapy with atomoxetine-oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: A randomized trial
Respirology. 2021 Sept;26:878–886.
A low exhaled nitric oxide level excludes a short-term benefit from inhaled corticosteroids in suspected asthma: A randomized placebo-controlled trial
Respirology. 2021; 26(7): 666-672
Impact of structured curriculum with simulation on bronchoscopy
Respirology. 2021; 26(6): 597-603
Preoperative use of pirfenidone and reduced risk of postoperative severe respiratory complications in patients with idiopathic pulmonary fibrosis: Propensity score-matched analysis using a nationwide database in Japan
Respirology. 2021; 26(6): 590-596
ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma
Respirology. 2021 May;26(5):442-451
Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective ‘target trial’ emulated with Swedish real-world data
Respirology. 2021 May; 26(5): 452-460
Endobronchial coil spring fiducial markers for CyberKnife® stereotactic body radiation therapy
Respirology. 2021 May; 26(5):469-476
Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression
Respirology. 2021 May; 26(5): 461-468
Cone-beam computed tomography versus computed tomography-guided ultrathin bronchoscopic diagnosis for peripheral pulmonary lesions: A propensity score-matched analysis
Respirology. 2021 May; 26(5): 477-484
Impact of cold and flu medication on obstructive sleep apnoea and its underlying traits: A pilot randomized controlled trial
Respirology. 2021 May; 26(5): 485-492
